BRCA1 and familial pancreatic carcinoma: The aim of our study was to investigate the effect of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression on the objective efficacy and survival conditions of patients with unresectable pancreatic cancer.